Basel, 11 December 2013
Many recent issue published by MDPI are missing from Web of Science (access point for the Science Citation Index Expanded, the Social Sciences Citation Index and the Arts & Humanities Citation Index), as many of our authors have pointed out to us. We have made extensive efforts to get in touch with Thomson Reuters to see how we can actively help to solve this problem. Thomson Reuters' has so far not provided any detailed explanation as to why the issues have not been indexed, but told us in a phone conversation that they are currently experiencing "technical issues with XML indexing". We are working on having this issue resolved as quickly as possible, but please note that the timely indexing of issues in beyond the control of MDPI.
As the end of the year is approaching and faculty members may need to report on published and indexed papers for their end-of-year review, we suggest turning to the more extensive SciVerse SCOPUS indexing database, which is published by Elsevier. Apart from the journal Religions, all MDPI journals covered by Thomson Reuters' Web of Science are also covered by Elsevier's SciVerse SCOPUS.
Note that, similar to Web of Science, SciVerse SCOPUS also offers citation tracking and a journal ranking system (http://www.scimagojr.com/). Additionally, in 2013 MDPI has started to use article level metrics through Altmetric.com and we have been offering statistics on downloads per article since 2009. We suggest that you use these metrics in your report until the latest issues from MDPI journals appear in Web of Science.
For more information, please contact:
Dr. Martyn Rittman
We are pleased to report an increased Impact Factor for Marine Drugs for 2012. According to the newly released 2012 Journal Citation Reports® Science Edition (Thomson Reuters, 2013), the new Impact Factor for Marine Drugs is 3.978. The 5-Year Impact Factor is 3.911. Marine Drugs now ranks 6/59 (Q1) in the category 'Chemistry, Medicinal'.
Evolution of the Marine Drugs Impact Factor since 2006:
Evolution of citations to Marine Drugs since 2006:
With the start of 2013, Marine Drugs is instituting an annual award to recognize outstanding papers related to the research, development and production of drugs from the sea, that meet the high standards of this journal. We are pleased to announce the “Marine Drugs Best Paper Award” for 2013. Nominations were solicited from the Editorial Board members, with all papers published in 2009 eligible for consideration.
1st prize: Jason C. Kwan, Kanchan Taori, Valerie J. Paul and Hendrik Luesch
Lyngbyastatins 8–10, Elastase Inhibitors with Cyclic Depsipeptide Scaffolds Isolated from the Marine Cyanobacterium Lyngbya semiplena.
2nd prize: Sigrid Hakvåg, Espen Fjærvik, Geir Klinkenberg, Sven Even F. Borgos, Kjell D. Josefsen, Trond E. Ellingsen and Sergey B. Zotchev
Violacein-Producing Collimonas sp. from the Sea Surface Microlayer of Coastal Waters in Trøndelag, Norway.
Barbara Forte, Beatrice Malgesini, Claudia Piutti, Francesca Quartieri, Alessandra Scolaro and Gianluca Papeo.
A Submarine Journey: The Pyrrole-Imidazole Alkaloids.
For more details, please refer to the Editorial by Prof. Dr. Hartmut Laatsch, Editor-in-Chief of Marine Drugs.